Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
With Vascepa’s New CV Claim, Amarin Targets Patients On Other Triglyceride-Lowering Agents
Dec 16 2019
•
By
Sue Sutter
Amarin finally has reeled in the big indication for Vascepa in the US. • Source: Shutterstock
More from Business
More from Scrip